Human antibodies cloned by scientists at the Lankenau Institute for Medical Research (LIMR) have been adopted by the World Health Organization (WHO) as a crucial part of its plan to eradicate polio permanently.
Announced on December 9, 2022, the WHO Expert Committee on Biological Standardization approved the antibodies created in the lab of LIMR faculty member Scott Dessain, MD, Ph.D., as the standard for quality-control testing of all inactivated polio vaccines (IPV) in October 2022.
Read More
